ChemBriefHims & Hers Raises Annual Revenue Forecast on Strong Subscriber Growth
Hims & Hers raised its full-year revenue guidance to $3.1–$3.3 billion after reporting $753 million in quarterly revenue. The growth was driven by a partnership with Novo Nordisk to offer the FDA-appr
reuters · 2026-08-10 13:10 UTC